Utilizing ELISA to monitor protein-protein interaction.

Enzyme-linked immunosorbent assay (ELISA) is a commonly used method in analyzing biomolecular interactions. As a rapid, specific, and easy-to-operate method, ELISA has been used as a research tool as well as a widely adopted diagnostic method in clinical settings and for microbial testing in various industries. Inhibition ELISA is a one-site binding analysis method, which can monitor protein-protein interactions in solution as opposed to more commonly used sandwich ELISA in which the analyte capture step is required on a solid surface either through specific capture or through passive adsorption. Here, we introduce inhibition ELISA procedures, using a recombinant viral protein as an example, with emphasis on how inhibition ELISA could be used to probe subtle protein conformational changes in solution impacting protein-protein binding affinity. Inhibition ELISA is used to probe one binding site at a time for binding partners in solution with unrestricted conformation. The assay can be performed in a quantitative manner with a serially diluted analyte in solution for solution antigenicity or binding activity assessment.

[1]  Y. Modis,et al.  Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity , 2012, Virology Journal.

[2]  Bruce D. Hammock,et al.  Competitive inhibition ELISA for the s-triazine herbicides : assay optimization and antibody characterization , 1991 .

[3]  R. Kennedy,et al.  Real time monitoring of antigenicity development of HBsAg virus-like particles (VLPs) during heat- and redox-treatment. , 2011, Biochemical and biophysical research communications.

[4]  Anke M. Mulder,et al.  Toolbox for Non-Intrusive Structural and Functional Analysis of Recombinant VLP Based Vaccines: A Case Study with Hepatitis B Vaccine , 2012, PloS one.

[5]  T. Thorne,et al.  PREVALENCE OF ANTIBODY TO MALIGNANT CATARRHAL FEVER VIRUS IN WILD AND DOMESTIC RUMINANTS BY COMPETITIVE-INHIBITION ELISA , 1996, Journal of wildlife diseases.

[6]  M. L. C. Cuervo,et al.  Validation of a new alternative for determining in vitro potency in vaccines containing Hepatitis B from two different manufacturers. , 2008, Biologicals : journal of the International Association of Biological Standardization.

[7]  H. Tai,et al.  Measurement of anti‐CD154 monoclonal antibody in primate sera by competitive inhibition ELISA , 2006, Xenotransplantation.

[8]  K. Catt,et al.  Solid-Phase Radioimmunoassay in Antibody-Coated Tubes , 1967, Science.

[9]  Qinjian Zhao,et al.  Enhanced sensitivity and precision in an enzyme-linked immunosorbent assay with fluorogenic substrates compared with commonly used chromogenic substrates. , 2005, Analytical biochemistry.

[10]  S A BERSON,et al.  Immunoassay of endogenous plasma insulin in man. , 1996, The Journal of clinical investigation.

[11]  R. Kennedy,et al.  In-depth process understanding of RECOMBIVAX HB® maturation and potential epitope improvements with redox treatment: multifaceted biochemical and immunochemical characterization. , 2011, Vaccine.

[12]  G. Ramathilagam,et al.  Detection of peste des petits ruminants virus antigen using immunofiltration and antigen-competition ELISA methods. , 2008, Veterinary microbiology.

[13]  Ramon Eritja,et al.  Oligonucleotide-Peptide Conjugates: Solid-Phase Synthesis under Acidic Conditions and Use in ELISA Assays , 2012, Molecules.

[14]  J. Wetzels,et al.  Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[15]  L. Pinto,et al.  Correlation between direct ELISA, single epitope-based inhibition ELISA and Pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine , 2008, Human vaccines.

[16]  M. L. C. Cuervo,et al.  Comparison between in vitro potency tests for Cuban hepatitis B vaccine: contribution to the standardization process. , 2004, Biologicals : journal of the International Association of Biological Standardization.

[17]  M. Duchêne,et al.  Validation of a new ELISA method for in vitro potency assay of hepatitis B-containing vaccines. , 2006, Pharmeuropa bio.

[18]  Qinjian Zhao,et al.  Determination of picomolar equilibrium dissociation constants in solution by enzyme-linked immunosorbent assay with fluorescence detection. , 2005, Analytical biochemistry.

[19]  G. Kuchel,et al.  ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[20]  A. Chaffotte,et al.  Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. , 1985, Journal of immunological methods.